Hello, Fool! | Login | Signup | My Fool
Sep 6, 2008 9:32 PM ET | Site Changes | Help
A biotechnology company focused on the development and commercialization of novel biological therapies for patients with cancer.
View Ticker Page (CEGE)
Results 41 - 50 of 58 : 12345Next »
Recs
mattjetfan (< 20) Submitted: 8/11/08 11:53 PM : Start Price: $3.09 CEGE Score: -71.20
NIce stock. Very Very Volatile, hopefully will continue to climb.
Report this Post Replies: 0 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
spiderM9 (< 20) Submitted: 12/18/06 1:25 AM : Start Price: $3.54 CEGE Score: -66.10
Just got dumped for end of year tax losses, will pick up a bit in the middle of January.
krips (< 20) Submitted: 12/19/06 2:28 PM : Start Price: $3.44 CEGE Score: -66.03
Confirmed news that CEGE is going to be bought out within the next 6 months - target price is $8.00 a share.
SwissBioFreak (28.23) Submitted: 4/15/07 7:59 AM : Start Price: $5.30 CEGE Score: -71.17
Enrolling now patients for phase ii trials. If this is successfull the stock will soar.
falvino (83.15) Submitted: 6/12/07 6:41 PM : Start Price: $3.73 CEGE Score: 62.56
nothing there yet
rdjville (24.73) Submitted: 3/30/07 11:33 PM : Start Price: $4.20 CEGE Score: -69.66
couple of drugs in line for fda approval
madkd1 (< 20) Submitted: 3/22/07 7:18 PM : Start Price: $3.06 CEGE Score: -62.33
Genetically targeted cancer treatment. Introduce viruses that can only attack mutated cancerous DNA not healthy DNA.
JesterJay (52.55) Submitted: 3/21/07 7:54 PM : Start Price: $3.03 CEGE Score: -61.96
Great Pipeline, Bright People, History of innovation, valuation. If Provenge fails (Who knows??) GVAX could eventually have positive benefit??
fahadhabib (26.20) Submitted: 1/15/07 1:57 PM : Start Price: $3.15 CEGE Score: -63.15
Good one..
agard43 (65.21) Submitted: 2/18/07 2:42 PM : Start Price: $3.55 CEGE Score: -64.35
2/19/1007 Business Week Article
Terms & Conditions
RSS Headlines
Fool UK